LiDCO (LID.L), a hemodynamic monitoring company, Tuesday said it has been awarded a five-year purchasing agreement by MedAssets, a US-based group purchasing organization.
The agreement has the potential to substantially enhance the company's business in the U.S. as it opens up sales into 38 new US hospitals.
Separately, the firm said its first-half loss before tax widened to 689,000 pounds from last year's 230,000 pounds.
Excluding share-based payments and exceptional items, loss before tax widened to 525,000 pounds from 190,000 pounds in the previous year, after planned increase in sales infrastructure costs.
Loss per share widened to 0.36 pence from 0.13 pence.
Total revenue fell to 3.60 million pounds from 3.71 million pounds in the previous year.
Looking ahead, results for the year as a whole are expected to be broadly breakeven, before the exceptional costs relating to replacing the CEO.
The stock climbed 10 percent in early trade to 10.45 pence.
For comments and feedback: editorial@rttnews.com